Literature DB >> 17280745

Prevention of pertussis: recommendations derived from the second Global Pertussis Initiative roundtable meeting.

Kevin D Forsyth1, Carl-Heinz Wirsing von Konig, Tina Tan, Jaime Caro, Stanley Plotkin.   

Abstract

The Global Pertussis Initiative (GPI) was established in 2001 to assess the global extent of the ongoing problem of pertussis and to evaluate and prioritize pertussis control strategies. Exchange of data, knowledge, and experience, facilitated by discussion and debate, resulted in the formulation, in 2002, of the following recommendation: all countries should consider expanding existing vaccination strategies to include adding pertussis booster doses to pre-school children (4-6 years old), to adolescents, and to those specific adults that have the highest risk of transmitting Bordetella pertussis infection to vulnerable infants. The GPI met again in 2005, where it reinforced its previous recommendation for universal adolescent immunization. Additionally, the GPI recommended implementation of the cocoon strategy (immunization of family members and close contacts of the newborn) in countries where it is economically feasible, and encouraged efforts toward global standardization of pertussis disease clinical definitions and diagnostics. Universal adult vaccination is a logical goal for the ultimate elimination of pertussis disease, but feasibility issues remain obstacles to implementation.

Entities:  

Mesh:

Year:  2006        PMID: 17280745     DOI: 10.1016/j.vaccine.2006.12.017

Source DB:  PubMed          Journal:  Vaccine        ISSN: 0264-410X            Impact factor:   3.641


  40 in total

1.  Antibody response from whole-cell pertussis vaccine immunized Brazilian children against different strains of Bordetella pertussis.

Authors:  Alexandre Pereira; Aparecida S Pietro Pereira; Célio Lopes Silva; Gutemberg de Melo Rocha; Ivo Lebrun; Osvaldo A Sant'Anna; Denise V Tambourgi
Journal:  Am J Trop Med Hyg       Date:  2010-04       Impact factor: 2.345

2.  Recent findings on pertussis epidemiology in Turkey.

Authors:  D Dilli; I Bostanci; Y Dallar; T Buzgan; H Irmak; M A Torunoğlu
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2008-01-09       Impact factor: 3.267

3.  How long can we expect pertussis protection to last after the adolescent booster dose of tetanus-diphtheria-pertussis (Tdap) vaccines?

Authors:  Nawaf Al Dajani; David Scheifele
Journal:  Paediatr Child Health       Date:  2007-12       Impact factor: 2.253

4.  Development and analytical validation of an immunoassay for quantifying serum anti-pertussis toxin antibodies resulting from Bordetella pertussis infection.

Authors:  Sandra L Menzies; Vijay Kadwad; Lucia C Pawloski; Tsai-Lien Lin; Andrew L Baughman; Monte Martin; Maria Lucia C Tondella; Bruce D Meade
Journal:  Clin Vaccine Immunol       Date:  2009-10-28

5.  Immunization of teenagers with a fifth dose of reduced DTaP-IPV induces high levels of pertussis antibodies with a significant increase in opsonophagocytic activity.

Authors:  Audun Aase; Tove Karin Herstad; Samuel Merino; Merete Bolstad; Synne Sandbu; Hilde Bakke; Ingeborg S Aaberge
Journal:  Clin Vaccine Immunol       Date:  2011-06-15

6.  The impact of adolescent pertussis immunization, 2004-2009: lessons from Australia.

Authors:  Helen E Quinn; Peter B McIntyre
Journal:  Bull World Health Organ       Date:  2011-07-05       Impact factor: 9.408

7.  Protecting infants from pertussis.

Authors:  Meghan Gilley; Ran D Goldman
Journal:  Can Fam Physician       Date:  2014-02       Impact factor: 3.275

8.  Characteristics of pertussis outbreaks in Catalonia, Spain, 1997 to 2010.

Authors:  Inma Crespo; Sonia Broner; Núria Soldevila; Ana Martínez; Pere Godoy; Maria-Rosa Sala-Farré; Maria Company; Cristina Rius; Angela Domínguez; The Pertussis Working Group Of Catalonia
Journal:  Hum Vaccin Immunother       Date:  2014-11-01       Impact factor: 3.452

9.  The distribution over time of costs and social net benefits for pertussis immunization programs.

Authors:  Dorota Zdanowska Girard
Journal:  Int J Health Care Finance Econ       Date:  2009-03-18

Review 10.  Pertussis re-emergence in the post-vaccination era.

Authors:  Elena Chiappini; Alessia Stival; Luisa Galli; Maurizio de Martino
Journal:  BMC Infect Dis       Date:  2013-03-26       Impact factor: 3.090

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.